2022 Q3 Form 10-Q Financial Statement

#000106163022000036 Filed on July 27, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $358.6M $283.7M $234.4M
YoY Change 79.18% 44.51% 25.01%
Cost Of Revenue $228.3M $163.7M $124.2M
YoY Change 123.74% 57.54% 27.28%
Gross Profit $130.3M $120.0M $110.2M
YoY Change 32.82% 29.86% 22.55%
Gross Profit Margin 36.33% 42.3% 47.02%
Selling, General & Admin $10.91M $11.11M $11.35M
YoY Change 8.61% 10.41% 14.58%
% of Gross Profit 8.38% 9.26% 10.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $12.93M $12.41M $12.36M
YoY Change 19.29% 16.31% 16.64%
Operating Profit $117.3M $107.6M $97.87M
YoY Change 34.5% 31.63% 23.35%
Interest Expense $202.4M $136.6M $100.7M
YoY Change 144.74% 65.9% 28.44%
% of Operating Profit 172.47% 126.98% 102.89%
Other Income/Expense, Net
YoY Change
Pretax Income $105.1M $94.61M $100.4M
YoY Change 24.41% -28.67% 24.51%
Income Tax $1.200M $746.0K $146.0K
% Of Pretax Income 1.14% 0.79% 0.15%
Net Earnings $103.2M $93.25M $99.69M
YoY Change 23.27% -29.14% 24.76%
Net Earnings / Revenue 28.79% 32.87% 42.52%
Basic Earnings Per Share $0.60 $0.55 $0.59
Diluted Earnings Per Share $0.59 $0.54 $0.58
COMMON SHARES
Basic Shares Outstanding 170.3M shares 170.7M shares 169.3M shares
Diluted Shares Outstanding 185.3M shares 185.0M shares 175.6M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $271.9M $283.6M $309.4M
YoY Change 28.75% -2.06% 10.46%
Cash & Equivalents $271.9M $283.6M $309.4M
Short-Term Investments
Other Short-Term Assets $4.265M $253.1M $23.67M
YoY Change 427.19% 212.71% 144.18%
Inventory
Prepaid Expenses
Receivables $146.9M $123.5M $94.94M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $423.0M $660.2M $428.0M
YoY Change 45.54% 49.04% 19.8%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Assets
YoY Change
Total Long-Term Assets $24.38B $24.78B $23.64B
YoY Change 19.4% 41.95% 39.08%
TOTAL ASSETS
Total Short-Term Assets $423.0M $660.2M $428.0M
Total Long-Term Assets $24.38B $24.78B $23.64B
Total Assets $24.80B $25.44B $24.07B
YoY Change 19.77% 42.13% 38.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.272M $7.899M $11.01M
YoY Change -34.37% 2.25% 190.83%
Accrued Expenses $83.59M $82.40M $60.97M
YoY Change 85.29% 95.39% 47.53%
Deferred Revenue
YoY Change
Short-Term Debt $9.275M $8.434M $6.254M
YoY Change 78.26% 108.92%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $206.1M $204.3M $183.8M
YoY Change 29.83% 40.83% 34.88%
LONG-TERM LIABILITIES
Long-Term Debt $19.91B $20.55B $19.21B
YoY Change 22.3% 49.07% 44.61%
Other Long-Term Liabilities $3.281M $24.71M $6.512M
YoY Change 384.64% 79.69% -78.87%
Total Long-Term Liabilities $19.91B $20.58B $19.22B
YoY Change 22.31% 49.1% 44.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $206.1M $204.3M $183.8M
Total Long-Term Liabilities $19.91B $20.58B $19.22B
Total Liabilities $20.11B $20.78B $19.40B
YoY Change 22.13% 48.74% 44.0%
SHAREHOLDERS EQUITY
Retained Earnings -$814.5M -$811.6M -$799.0M
YoY Change
Common Stock $5.469B $5.442B $5.433B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.658B $4.638B $4.643B
YoY Change
Total Liabilities & Shareholders Equity $24.80B $25.44B $24.07B
YoY Change 19.77% 42.13% 38.69%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $103.2M $93.25M $99.69M
YoY Change 23.27% -29.14% 24.76%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $83.01M $93.50M $90.10M
YoY Change -7.4% 13.57% 8.49%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $204.4M -$1.716B -$1.689B
YoY Change -106.81% 327.45% 222.53%
Cash From Investing Activities $204.4M -$1.716B -$1.689B
YoY Change -106.81% 327.45% 222.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $52.16M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -292.6M 1.604B $1.360B
YoY Change -110.41% 328.43% 215.06%
NET CHANGE
Cash From Operating Activities 83.01M 93.50M $90.10M
Cash From Investing Activities 204.4M -1.716B -$1.689B
Cash From Financing Activities -292.6M 1.604B $1.360B
Net Change In Cash -5.201M -18.07M -$238.6M
YoY Change -94.84% -132.64% 2595.58%
FREE CASH FLOW
Cash From Operating Activities $83.01M $93.50M $90.10M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei City Area Code
CityAreaCode
212
dei Entity Central Index Key
EntityCentralIndexKey
0001061630
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-14788
dei Entity Registrant Name
EntityRegistrantName
Blackstone Mortgage Trust, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-6181186
dei Entity Address Address Line1
EntityAddressAddressLine1
345 Park Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
24th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10154
dei Local Phone Number
LocalPhoneNumber
655-0220
dei Security12b Title
Security12bTitle
Class A common stock,
dei Trading Symbol
TradingSymbol
BXMT
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
170297049 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
283580000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
551154000 usd
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
24831546000 usd
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
22003017000 usd
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
133024000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
124679000 usd
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24698522000 usd
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
21878338000 usd
CY2022Q2 us-gaap Other Assets
OtherAssets
461145000 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
273797000 usd
CY2022Q2 us-gaap Assets
Assets
25443247000 usd
CY2021Q4 us-gaap Assets
Assets
22703289000 usd
CY2022Q2 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
13905949000 usd
CY2021Q4 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
12280042000 usd
CY2022Q2 bxmt Securitized Debt Obligations Net
SecuritizedDebtObligationsNet
2841901000 usd
CY2021Q4 bxmt Securitized Debt Obligations Net
SecuritizedDebtObligationsNet
2838062000 usd
CY2022Q2 bxmt Asset Specific Debt Agreements Net
AssetSpecificDebtAgreementsNet
860007000 usd
CY2021Q4 bxmt Asset Specific Debt Agreements Net
AssetSpecificDebtAgreementsNet
393824000 usd
CY2022Q2 us-gaap Participating Mortgage Loans Participation Liabilities Amount
ParticipatingMortgageLoansParticipationLiabilitiesAmount
225884000 usd
CY2021Q4 us-gaap Participating Mortgage Loans Participation Liabilities Amount
ParticipatingMortgageLoansParticipationLiabilitiesAmount
0 usd
CY2022Q2 us-gaap Secured Long Term Debt
SecuredLongTermDebt
1809942000 usd
CY2021Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
1327406000 usd
CY2022Q2 us-gaap Senior Notes
SeniorNotes
394562000 usd
CY2021Q4 us-gaap Senior Notes
SeniorNotes
394010000 usd
CY2022Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
512994000 usd
CY2021Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
619876000 usd
CY2022Q2 us-gaap Other Liabilities
OtherLiabilities
229021000 usd
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
231358000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
20780260000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
18084578000 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q2 us-gaap Minority Interest
MinorityInterest
25396000 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
30524000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4662987000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4618711000 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
170295049 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
170295049 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
168179798 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168179798 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1703000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1682000 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5440364000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5373029000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7078000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8308000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-811554000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-794832000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4637591000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4588187000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25443247000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22703289000 usd
CY2022Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
283687000 usd
CY2021Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
196303000 usd
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
518119000 usd
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
383827000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
136619000 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
82352000 usd
us-gaap Interest Expense
InterestExpense
237333000 usd
us-gaap Interest Expense
InterestExpense
160723000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
147068000 usd
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
113951000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
280786000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
223104000 usd
CY2022Q2 us-gaap Management Fee Expense
ManagementFeeExpense
27065000 usd
CY2021Q2 us-gaap Management Fee Expense
ManagementFeeExpense
21545000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
195020000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
50551000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
40752000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12409000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10669000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24769000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21267000 usd
CY2022Q2 us-gaap Noninterest Expense
NoninterestExpense
39474000 usd
CY2021Q2 us-gaap Noninterest Expense
NoninterestExpense
32214000 usd
us-gaap Noninterest Expense
NoninterestExpense
75320000 usd
us-gaap Noninterest Expense
NoninterestExpense
62019000 usd
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
12983000 usd
CY2021Q2 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
-50906000 usd
us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
10446000 usd
us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
-52199000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
94611000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
132643000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
213284000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
746000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
175000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
892000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
276000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
93865000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
132468000 usd
us-gaap Profit Loss
ProfitLoss
194128000 usd
us-gaap Profit Loss
ProfitLoss
213008000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
615000 usd
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
873000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1191000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1511000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
93250000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
131595000 usd
us-gaap Net Income Loss
NetIncomeLoss
192937000 usd
us-gaap Net Income Loss
NetIncomeLoss
211497000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.44
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.44
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170665601 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147342822 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169963730 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147339895 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
185009805 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147342822 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180332341 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147339895 shares
CY2022Q2 us-gaap Profit Loss
ProfitLoss
93865000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
132468000 usd
us-gaap Profit Loss
ProfitLoss
194128000 usd
us-gaap Profit Loss
ProfitLoss
213008000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-130207000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
15553000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-175429000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-19404000 usd
CY2022Q2 bxmt Other Comprehensive Income Realized And Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeRealizedAndUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
128685000 usd
CY2021Q2 bxmt Other Comprehensive Income Realized And Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeRealizedAndUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-16094000 usd
bxmt Other Comprehensive Income Realized And Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeRealizedAndUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
174199000 usd
bxmt Other Comprehensive Income Realized And Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeRealizedAndUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
18977000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1522000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-541000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1230000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-427000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
92343000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
131927000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
192898000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
212581000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
615000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
873000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1191000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1511000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
91728000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
131054000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
191707000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
211070000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4618711000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
52159000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
8472000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
246000 usd
CY2022Q1 bxmt Adjustments To Additional Paid In Capital Deferred Compensation
AdjustmentsToAdditionalPaidInCapitalDeferredCompensation
173000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
100263000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
292000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2022Q1 us-gaap Dividends
Dividends
105801000 usd
CY2022Q1 bxmt Cash Contributions From Joint Venture Partners That Increase Equity
CashContributionsFromJointVenturePartnersThatIncreaseEquity
5040000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
9241000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4669837000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
8245000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
319000 usd
CY2022Q2 bxmt Adjustments To Additional Paid In Capital Deferred Compensation
AdjustmentsToAdditionalPaidInCapitalDeferredCompensation
173000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
93865000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1522000 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2022Q2 us-gaap Dividends
Dividends
105812000 usd
CY2022Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
2118000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4662987000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3904231000 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
7958000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
204000 usd
CY2021Q1 bxmt Adjustments To Additional Paid In Capital Deferred Compensation
AdjustmentsToAdditionalPaidInCapitalDeferredCompensation
125000 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
80540000 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
114000 usd
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2021Q1 us-gaap Dividends
Dividends
91349000 usd
CY2021Q1 bxmt Cash Contributions From Joint Venture Partners That Increase Equity
CashContributionsFromJointVenturePartnersThatIncreaseEquity
13448000 usd
CY2021Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
11180000 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3904093000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
7895000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
211000 usd
us-gaap Profit Loss
ProfitLoss
213008000 usd
CY2021Q2 bxmt Adjustments To Additional Paid In Capital Deferred Compensation
AdjustmentsToAdditionalPaidInCapitalDeferredCompensation
125000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
132468000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-541000 usd
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2021Q2 us-gaap Dividends
Dividends
91347000 usd
CY2021Q2 bxmt Cash Contributions From Joint Venture Partners That Increase Equity
CashContributionsFromJointVenturePartnersThatIncreaseEquity
14745000 usd
CY2021Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
10694000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3956955000 usd
us-gaap Profit Loss
ProfitLoss
194128000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
17068000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
16105000 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
38740000 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
28674000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
22059000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
19277000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
2183131000 usd
bxmt Increase Decrease In Current Expected Credit Loss Reserve
IncreaseDecreaseInCurrentExpectedCreditLossReserve
10446000 usd
bxmt Increase Decrease In Current Expected Credit Loss Reserve
IncreaseDecreaseInCurrentExpectedCreditLossReserve
-52199000 usd
us-gaap Difference Between Reported Amount And Reporting Currency Denominated Amount Value
DifferenceBetweenReportedAmountAndReportingCurrencyDenominatedAmountValue
-31000 usd
us-gaap Difference Between Reported Amount And Reporting Currency Denominated Amount Value
DifferenceBetweenReportedAmountAndReportingCurrencyDenominatedAmountValue
-7065000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
713000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-635000 usd
bxmt Realized Gains Losses On Derivative Financial Instruments Net
RealizedGainsLossesOnDerivativeFinancialInstrumentsNet
4326000 usd
bxmt Realized Gains Losses On Derivative Financial Instruments Net
RealizedGainsLossesOnDerivativeFinancialInstrumentsNet
-3119000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
39865000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4261000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
23570000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
5428000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
183596000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
165373000 usd
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
5589977000 usd
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
3636063000 usd
us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
2004323000 usd
us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
2670773000 usd
us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
58716000 usd
us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
41262000 usd
bxmt Proceeds From Derivative Instruments In Investing Activities
ProceedsFromDerivativeInstrumentsInInvestingActivities
129010000 usd
bxmt Proceeds From Derivative Instruments In Investing Activities
ProceedsFromDerivativeInstrumentsInInvestingActivities
23194000 usd
bxmt Payments For Derivative Instruments In Investing Activities
PaymentsForDerivativeInstrumentsInInvestingActivities
6528000 usd
bxmt Payments For Derivative Instruments In Investing Activities
PaymentsForDerivativeInstrumentsInInvestingActivities
72478000 usd
bxmt Payments For Collateral Deposits Related To Derivatives
PaymentsForCollateralDepositsRelatedToDerivatives
0 usd
bxmt Payments For Collateral Deposits Related To Derivatives
PaymentsForCollateralDepositsRelatedToDerivatives
81430000 usd
bxmt Proceeds From Collateral Deposits Related To Derivatives
ProceedsFromCollateralDepositsRelatedToDerivatives
0 usd
bxmt Proceeds From Collateral Deposits Related To Derivatives
ProceedsFromCollateralDepositsRelatedToDerivatives
129770000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3404456000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-924972000 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
4246219000 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
4230404000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
3332395000 usd
bxmt Proceeds From Issuance Of Collateralized Loan Obligations
ProceedsFromIssuanceOfCollateralizedLoanObligations
0 usd
bxmt Proceeds From Issuance Of Collateralized Loan Obligations
ProceedsFromIssuanceOfCollateralizedLoanObligations
803750000 usd
bxmt Repayments For Collateralized Loan Obligations
RepaymentsForCollateralizedLoanObligations
0 usd
bxmt Repayments For Collateralized Loan Obligations
RepaymentsForCollateralizedLoanObligations
888763000 usd
bxmt Proceeds From Asset Specific Debt Agreements
ProceedsFromAssetSpecificDebtAgreements
551893000 usd
bxmt Proceeds From Asset Specific Debt Agreements
ProceedsFromAssetSpecificDebtAgreements
77975000 usd
bxmt Repayments Of Asset Specific Debt Agreements
RepaymentsOfAssetSpecificDebtAgreements
78659000 usd
bxmt Repayments Of Asset Specific Debt Agreements
RepaymentsOfAssetSpecificDebtAgreements
178073000 usd
bxmt Proceeds From Sale Of Loan Participation
ProceedsFromSaleOfLoanParticipation
245278000 usd
bxmt Proceeds From Sale Of Loan Participation
ProceedsFromSaleOfLoanParticipation
0 usd
bxmt Proceeds From Issuance Of Secured Term Loan
ProceedsFromIssuanceOfSecuredTermLoan
492500000 usd
bxmt Proceeds From Issuance Of Secured Term Loan
ProceedsFromIssuanceOfSecuredTermLoan
298500000 usd
bxmt Repayments Of Secured Term Loans
RepaymentsOfSecuredTermLoans
6869000 usd
bxmt Repayments Of Secured Term Loans
RepaymentsOfSecuredTermLoans
6625000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
294000000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
402500000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
30489000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
22811000 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
5040000 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
28193000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
11359000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
21874000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
52155000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
209847000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
182163000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2964231000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
806118000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-256629000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
46519000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
551154000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
289970000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-10945000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3063000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
283580000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
339552000 usd
us-gaap Interest Paid Net
InterestPaidNet
188611000 usd
us-gaap Interest Paid Net
InterestPaidNet
140601000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
407000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-141000 usd
bxmt Dividends Declared And Not Paid
DividendsDeclaredAndNotPaid
105583000 usd
bxmt Dividends Declared And Not Paid
DividendsDeclaredAndNotPaid
91150000 usd
bxmt Loan Principal Payments Held By Servicer
LoanPrincipalPaymentsHeldByServicer
189909000 usd
bxmt Loan Principal Payments Held By Servicer
LoanPrincipalPaymentsHeldByServicer
27612000 usd
us-gaap Nature Of Operations
NatureOfOperations
ORGANIZATION <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">References herein to “Blackstone Mortgage Trust,” “Company,” “we,” “us” or “our” refer to Blackstone Mortgage Trust, Inc. and its subsidiaries unless the context specifically requires otherwise. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Blackstone Mortgage Trust is a real estate finance company that originates senior loans collateralized by commercial real estate in North America, Europe, and Australia. Our portfolio is composed primarily of loans secured by high-quality, institutional assets in major markets, sponsored by experienced, well-capitalized real estate investment owners and operators. These senior loans are capitalized by accessing a variety of financing options, including borrowing under our credit facilities, issuing CLOs or single-asset securitizations, and syndicating senior loan participations, depending on our view of the most prudent financing option available for each of our investments. We are not in the business of buying or trading securities, and the only securities we own are the retained interests from our securitization financing transactions, which we have not financed. We are externally managed by BXMT Advisors L.L.C., or our Manager, a subsidiary of Blackstone Inc., or Blackstone, and are a real estate investment trust, or REIT, traded on the New York Stock Exchange, or NYSE, under the symbol “BXMT.” Our principal executive offices are located at 345 Park Avenue, 24th Floor, New York, New York 10154. We were incorporated in Maryland in 1998, when we reorganized from a California common law business trust into a Maryland corporation. </span></div>We conduct our operations as a REIT for U.S. federal income tax purposes. We generally will not be subject to U.S. federal income taxes on our taxable income to the extent that we annually distribute all of our net taxable income to stockholders and maintain our qualification as a REIT. We also operate our business in a manner that permits us to maintain an exclusion from registration under the Investment Company Act of 1940, as amended. We are organized as a holding company and conduct our business primarily through our various subsidiaries.
CY2017Q2 bxmt Joint Venture Capital Contribution Percentage
JointVentureCapitalContributionPercentage
0.85
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Use of Estimates </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. As the novel coronavirus, or COVID-19, pandemic has evolved from its emergence in early 2020, so has its global impact. During the course of the pandemic, many countries have re-instituted, or strongly encouraged, varying levels of quarantines and restrictions on travel and in some cases have at times limited operations of certain businesses and taken other restrictive measures designed to help slow the spread of COVID-19 and its variants. Governments and businesses have also instituted vaccine mandates and testing requirements for employees. While vaccine availability and uptake has increased, the longer-term macro-economic effects on global supply chains, inflation, labor shortages and wage increases continue to impact many industries, including the collateral underlying certain of our loans. Moreover, with the potential for new strains of COVID-19 or outbreaks of other infectious diseases, governments and businesses may re-impose aggressive measures to help slow the spread of infectious diseases in the future. For this reason, among others, as the COVID-19 pandemic continues, the potential global impacts are uncertain and difficult to assess. We believe the estimates and assumptions underlying our consolidated financial statements are reasonable and supportable based on the information available as of June 30, 2022, however uncertainty over the ultimate impact of COVID-19, rising inflation and increases in interest rates on the global economy generally, and our business in particular, makes any estimates and assumptions as of June 30, 2022 inherently less certain than they would be absent the current and potential impacts of COVID-19, macroeconomic changes, and geopolitical events. Actual results may ultimately differ materially from those estimates.</span></div>
us-gaap Revenue Recognition Interest
RevenueRecognitionInterest
Revenue Recognition Interest income from our loans receivable portfolio and debt securities is recognized over the life of each investment using the effective interest method and is recorded on the accrual basis. Recognition of fees, premiums, and discounts associated with these investments is deferred and recorded over the term of the loan or debt security as an adjustment to yield. Income accrual is generally suspended for loans at the earlier of the date at which payments become 90 days past due or when, in our opinion, recovery of income and principal becomes doubtful. Interest received is then recorded as a reduction in the outstanding principal balance until accrual is resumed when the loan becomes contractually current and performance is demonstrated to be resumed. In addition, for loans we originate, the related origination expenses are deferred and recognized as a component of interest income, however expenses related to loans we acquire are included in general and administrative expenses as incurred.
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
283580000 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
289552000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 usd
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
50000000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
283580000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
339552000 usd
CY2022Q2 us-gaap Escrow Deposit
EscrowDeposit
623300000 usd
CY2021Q4 us-gaap Escrow Deposit
EscrowDeposit
531200000 usd
CY2022Q2 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
205 securityloan
CY2021Q4 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
188 securityloan
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
25001207000 usd
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
22156437000 usd
CY2021Q4 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
-153420000 usd
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24698522000 usd
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
21878338000 usd
bxmt Mortgage Loan On Real Estate Final Maturity Term
MortgageLoanOnRealEstateFinalMaturityTerm
P3Y6M
CY2021 bxmt Mortgage Loan On Real Estate Final Maturity Term
MortgageLoanOnRealEstateFinalMaturityTerm
P3Y4M24D
CY2021Q4 bxmt Financing Receivable Number Of Loans Accounted For Under Cost Recovery Method
FinancingReceivableNumberOfLoansAccountedForUnderCostRecoveryMethod
1 loan
CY2022Q2 bxmt Financing Receivable Number Of Loans Accounted For Under Cost Recovery Method
FinancingReceivableNumberOfLoansAccountedForUnderCostRecoveryMethod
1 loan
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
25001207000 usd
CY2022Q2 bxmt Mortgage Loans On Real Estate Accounted For Under Cost Recovery Method
MortgageLoansOnRealEstateAccountedForUnderCostRecoveryMethod
286300000 usd
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
22156437000 usd
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
22003017000 usd
bxmt Financing Receivable New Issue
FinancingReceivableNewIssue
5589977000 usd
bxmt Financing Receivable New Issue
FinancingReceivableNewIssue
5589977000 usd
bxmt Financing Receivable Sale And Collection Of Finance Receivables
FinancingReceivableSaleAndCollectionOfFinanceReceivables
2101793000 usd
bxmt Financing Receivable Sale And Collection Of Finance Receivables
FinancingReceivableSaleAndCollectionOfFinanceReceivables
2101793000 usd
bxmt Financing Receivable Gain Loss On Foreign Currency Translation
FinancingReceivableGainLossOnForeignCurrencyTranslation
-643414000 usd
bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Gain Loss On Foreign Currency Translation
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountGainLossOnForeignCurrencyTranslation
4851000 usd
bxmt Financing Receivable Before Allowance For Credit Loss Fee And Loan In Process Gain Loss On Foreign Currency Translation
FinancingReceivableBeforeAllowanceForCreditLossFeeAndLoanInProcessGainLossOnForeignCurrencyTranslation
-638563000 usd
bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount New Issues
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountNewIssues
58716000 usd
bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount New Issues
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountNewIssues
58716000 usd
bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Amortization
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountAmortization
37624000 usd
bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Amortization
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountAmortization
37624000 usd
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
25001207000 usd
CY2022Q2 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
-169661000 usd
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
24831546000 usd
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
133024000 usd
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24698522000 usd
CY2022Q2 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
205 securityloan
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
24831546000 usd
CY2022Q2 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
26509461000 usd
CY2022Q2 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
133024000 usd
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24698522000 usd
CY2022Q2 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
205 securityloan
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
24831546000 usd
CY2022Q2 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
26509461000 usd
CY2022Q2 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
133024000 usd
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24698522000 usd
CY2022Q2 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1500000000 usd
CY2021Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1500000000 usd
CY2021Q4 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
188 securityloan
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
22003017000 usd
CY2021Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
23669111000 usd
CY2021Q4 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
124679000 usd
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
21878338000 usd
CY2021Q4 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
188 securityloan
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
22003017000 usd
CY2021Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
23669111000 usd
CY2021Q4 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
124679000 usd
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
21878338000 usd
CY2021Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1500000000 usd
CY2022Q2 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
205 securityloan
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
24831546000 usd
CY2022Q2 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
26509461000 usd
CY2021Q4 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
188 securityloan
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
22003017000 usd
CY2021Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
23669111000 usd
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
133024000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
124679000 usd
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24698522000 usd
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
21878338000 usd
CY2022Q2 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1500000000 usd
CY2021Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1500000000 usd
CY2021Q4 bxmt Weighted Average Risk Rating On Loan Exposure
WeightedAverageRiskRatingOnLoanExposure
2.8
CY2022Q2 bxmt Weighted Average Risk Rating On Loan Exposure
WeightedAverageRiskRatingOnLoanExposure
2.8
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
124679000 usd
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
-2458000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
122221000 usd
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
10803000 usd
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
133024000 usd
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
173549000 usd
CY2021Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
-1449000 usd
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
172100000 usd
CY2021Q2 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
-43155000 usd
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
128945000 usd
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
133024000 usd
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24698522000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
124679000 usd
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
21878338000 usd
CY2021Q4 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss
78000000.0 usd
CY2022Q2 bxmt Loan Portfolio Payments Held By Our Third Party Loan Servicer
LoanPortfolioPaymentsHeldByOurThirdPartyLoanServicer
252401000 usd
CY2021Q4 bxmt Loan Portfolio Payments Held By Our Third Party Loan Servicer
LoanPortfolioPaymentsHeldByOurThirdPartyLoanServicer
77624000 usd
CY2022Q2 us-gaap Interest Receivable
InterestReceivable
123517000 usd
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
86101000 usd
CY2022Q2 us-gaap Derivative Assets
DerivativeAssets
83982000 usd
CY2021Q4 us-gaap Derivative Assets
DerivativeAssets
30531000 usd
CY2022Q2 bxmt Accounts Receivable Net Current And Other Assets Current
AccountsReceivableNetCurrentAndOtherAssetsCurrent
503000 usd
CY2021Q4 bxmt Accounts Receivable Net Current And Other Assets Current
AccountsReceivableNetCurrentAndOtherAssetsCurrent
572000 usd
CY2022Q2 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
742000 usd
CY2021Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
956000 usd
CY2022Q2 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss
0 usd
CY2021Q4 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss
78083000 usd
CY2022Q2 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest
0 usd
CY2021Q4 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest
70000 usd
CY2022Q2 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss
0 usd
CY2021Q4 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss
78013000 usd
CY2022Q2 us-gaap Other Assets
OtherAssets
461145000 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
273797000 usd
CY2021Q4 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest
70000 usd
CY2022Q1 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
DebtSecuritiesHeldToMaturityExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
-70000 usd
CY2022Q1 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest
0 usd
CY2022Q2 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
DebtSecuritiesHeldToMaturityExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
0 usd
CY2022Q2 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest
0 usd
CY2020Q4 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest
1723000 usd
CY2021Q1 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
DebtSecuritiesHeldToMaturityExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
-834000 usd
CY2021Q1 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest
889000 usd
CY2021Q2 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
DebtSecuritiesHeldToMaturityExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
-767000 usd
CY2021Q2 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest
122000 usd
CY2022Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
105583000 usd
CY2021Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
104271000 usd
CY2022Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
55334000 usd
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
29851000 usd
CY2022Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
27065000 usd
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
28373000 usd
CY2022Q2 bxmt Secured Debt Repayments Pending Servicer Remittance
SecuredDebtRepaymentsPendingServicerRemittance
22117000 usd
CY2021Q4 bxmt Secured Debt Repayments Pending Servicer Remittance
SecuredDebtRepaymentsPendingServicerRemittance
47664000 usd
CY2022Q2 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
8434000 usd
CY2021Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
6263000 usd
CY2022Q2 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
7899000 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
9046000 usd
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2589000 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
5890000 usd
CY2022Q2 us-gaap Other Liabilities
OtherLiabilities
229021000 usd
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
231358000 usd
CY2022Q2 bxmt Debt Instrument Covenant Requirement On Consolidated Tangible Net Worth Minimum
DebtInstrumentCovenantRequirementOnConsolidatedTangibleNetWorthMinimum
3500000000 usd
CY2022Q2 bxmt Debt Instrument Covenant Maximum Percentage Of Cash Liquidity On Recourse Indebtedness
DebtInstrumentCovenantMaximumPercentageOfCashLiquidityOnRecourseIndebtedness
0.05
CY2022Q2 bxmt Credit Spread Adjustment
CreditSpreadAdjustment
0.0011
CY2022Q2 bxmt Interest Expense Secured Debt
InterestExpenseSecuredDebt
15500000 usd
bxmt Interest Expense Secured Debt
InterestExpenseSecuredDebt
26500000 usd
CY2021Q4 bxmt Credit Spread Adjustment
CreditSpreadAdjustment
0.0011
CY2021Q2 bxmt Interest Expense Secured Debt
InterestExpenseSecuredDebt
12400000 usd
bxmt Interest Expense Secured Debt
InterestExpenseSecuredDebt
24500000 usd
CY2022Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6300000 usd
CY2022Q2 us-gaap Share Price
SharePrice
27.67
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
5890000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
128685000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
174195000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
0 usd
CY2022Q2 us-gaap Derivative Assets
DerivativeAssets
83982000 usd
CY2021Q4 us-gaap Derivative Assets
DerivativeAssets
30531000 usd
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2589000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
4000 usd
us-gaap Interest Expense
InterestExpense
237300000 usd
CY2022Q2 bxmt Stock Shares Authorized
StockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
168543370 shares
CY2020Q4 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
147086722 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1678420 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
949 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
436831 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
234838 shares
us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
27455 shares
CY2022Q2 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
2781 shares
us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
21374 shares
CY2022Q2 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
170686076 shares
CY2021Q2 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
147343883 shares
CY2022Q2 bxmt Deferred Stock Units
DeferredStockUnits
391027 shares
CY2021Q2 bxmt Deferred Stock Units
DeferredStockUnits
328065 shares
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
3420 shares
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
949 shares
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
3420 shares
CY2021Q2 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
434 shares
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
949 shares
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.24
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.24
CY2022Q2 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
229000 usd
CY2021Q2 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
197000 usd
us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
455000 usd
us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
387000 usd
CY2022Q2 us-gaap Dividends
Dividends
105812000 usd
CY2021Q2 us-gaap Dividends
Dividends
91347000 usd
us-gaap Dividends
Dividends
211613000 usd
us-gaap Dividends
Dividends
182696000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
93250000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
131595000 usd
us-gaap Net Income Loss
NetIncomeLoss
192937000 usd
us-gaap Net Income Loss
NetIncomeLoss
211497000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170665601 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147342822 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169963730 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147339895 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.44
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
93250000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
131595000 usd
us-gaap Net Income Loss
NetIncomeLoss
192937000 usd
us-gaap Net Income Loss
NetIncomeLoss
211497000 usd
CY2022Q2 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
5913000 usd
CY2021Q2 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
8313000 usd
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
99163000 usd
CY2021Q2 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
131595000 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
201250000 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
211497000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170665601 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147342822 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169963730 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147339895 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
14344204 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
10368611 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
185009805 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147342822 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180332341 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147339895 shares
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.44
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7100000 usd
CY2022Q2 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
260600000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-253500000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8300000 usd
CY2021Q4 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
86400000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-78100000 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
2693000 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
2043000 usd
us-gaap Professional Fees
ProfessionalFees
5390000 usd
us-gaap Professional Fees
ProfessionalFees
3861000 usd
CY2022Q2 bxmt General And Administrative Operating And Other Costs
GeneralAndAdministrativeOperatingAndOtherCosts
1298000 usd
CY2021Q2 bxmt General And Administrative Operating And Other Costs
GeneralAndAdministrativeOperatingAndOtherCosts
606000 usd
bxmt General And Administrative Operating And Other Costs
GeneralAndAdministrativeOperatingAndOtherCosts
2311000 usd
bxmt General And Administrative Operating And Other Costs
GeneralAndAdministrativeOperatingAndOtherCosts
1301000 usd
CY2022Q2 bxmt Core General And Administrative Expenses
CoreGeneralAndAdministrativeExpenses
3991000 usd
CY2021Q2 bxmt Core General And Administrative Expenses
CoreGeneralAndAdministrativeExpenses
2649000 usd
bxmt Core General And Administrative Expenses
CoreGeneralAndAdministrativeExpenses
7701000 usd
bxmt Core General And Administrative Expenses
CoreGeneralAndAdministrativeExpenses
5162000 usd
CY2022Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
8245000 usd
CY2021Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
7895000 usd
us-gaap Restricted Stock Expense
RestrictedStockExpense
16723000 usd
us-gaap Restricted Stock Expense
RestrictedStockExpense
15855000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
173000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
125000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
345000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
250000 usd
CY2022Q2 bxmt Non Cash And Legacy Compensation Expenses
NonCashAndLegacyCompensationExpenses
8418000 usd
CY2021Q2 bxmt Non Cash And Legacy Compensation Expenses
NonCashAndLegacyCompensationExpenses
8020000 usd
bxmt Non Cash And Legacy Compensation Expenses
NonCashAndLegacyCompensationExpenses
17068000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10669000 usd
bxmt Non Cash And Legacy Compensation Expenses
NonCashAndLegacyCompensationExpenses
16105000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12409000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24769000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21267000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
746000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
892000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
175000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
276000 usd
CY2013Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
25875000 shares
CY2022Q2 bxmt Operating Loss Carryforwards Limitations On Use Annual Limitation
OperatingLossCarryforwardsLimitationsOnUseAnnualLimitation
2000000.0 usd
CY2022Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
159000000.0 usd
CY2022Q2 bxmt Number Of Benefit Plans
NumberOfBenefitPlans
9 plan
CY2022Q2 bxmt Number Of Expired Benefit Plans
NumberOfExpiredBenefitPlans
7 plan
CY2022Q2 bxmt Number Of Current Benefit Plans
NumberOfCurrentBenefitPlans
2 plan
CY2022Q2 bxmt Asset Specific Debt Gross
AssetSpecificDebtGross
870684000 usd
CY2021Q4 bxmt Asset Specific Debt Gross
AssetSpecificDebtGross
400699000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
283580000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
551154000 usd
CY2022Q2 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
25001207000 usd
CY2021Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
22156437000 usd
CY2022Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
0 usd
CY2021Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
79200000 usd
CY2022Q2 bxmt Securitized Debt Obligations Net Face Amount
SecuritizedDebtObligationsNetFaceAmount
2855625000 usd
CY2021Q4 bxmt Securitized Debt Obligations Net Face Amount
SecuritizedDebtObligationsNetFaceAmount
2855625000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1926052000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
6037649000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3331203000 usd
CY2022Q2 bxmt Participating Mortgage Loans Participation Liabilities Principal Amount
ParticipatingMortgageLoansParticipationLiabilitiesPrincipalAmount
226511000 usd
CY2021Q4 bxmt Participating Mortgage Loans Participation Liabilities Principal Amount
ParticipatingMortgageLoansParticipationLiabilitiesPrincipalAmount
0 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
91103000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
809081000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
4165039000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
1205394000 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
17565521000 usd
bxmt Debt Instrument Amortization Percentage
DebtInstrumentAmortizationPercentage
0.010
CY2022Q2 bxmt Securitized Debt Obligations Excluded From Contractual Obligations
SecuritizedDebtObligationsExcludedFromContractualObligations
2900000000 usd
CY2022Q2 bxmt Nonconsolidated Securitized Debt Excluded From Contractual Obligations
NonconsolidatedSecuritizedDebtExcludedFromContractualObligations
1500000000 usd
CY2022Q2 bxmt Participating Mortgage Loans Participation Liabilities Principal Amount
ParticipatingMortgageLoansParticipationLiabilitiesPrincipalAmount
226500000 usd
bxmt Board Of Directors Number Of Members
BoardOfDirectorsNumberOfMembers
9 director
bxmt Number Of Directors Eligible For Annual Compensation
NumberOfDirectorsEligibleForAnnualCompensation
6 director

Files In Submission

Name View Source Status
0001061630-22-000036-index-headers.html Edgar Link pending
0001061630-22-000036-index.html Edgar Link pending
0001061630-22-000036.txt Edgar Link pending
0001061630-22-000036-xbrl.zip Edgar Link pending
bxmt-20220630.htm Edgar Link pending
bxmt-20220630.xsd Edgar Link pending
bxmt-20220630_cal.xml Edgar Link unprocessable
bxmt-20220630_def.xml Edgar Link unprocessable
bxmt-20220630_g1.gif Edgar Link pending
bxmt-20220630_g2.jpg Edgar Link pending
bxmt-20220630_htm.xml Edgar Link completed
bxmt-20220630_lab.xml Edgar Link unprocessable
bxmt-20220630_pre.xml Edgar Link unprocessable
exhibit101.htm Edgar Link pending
exhibit1010.htm Edgar Link pending
exhibit1011.htm Edgar Link pending
exhibit102.htm Edgar Link pending
exhibit103.htm Edgar Link pending
exhibit104.htm Edgar Link pending
exhibit105.htm Edgar Link pending
exhibit108.htm Edgar Link pending
exhibit109.htm Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_01.jpg Edgar Link pending
image_03.jpg Edgar Link pending
image_0a.jpg Edgar Link pending
image_11a.jpg Edgar Link pending
image_1a.jpg Edgar Link pending
image_2a.jpg Edgar Link pending
image_3a.jpg Edgar Link pending
image_4a.jpg Edgar Link pending
image_5.jpg Edgar Link pending
image_6a.jpg Edgar Link pending
image_7a.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending